stockrow
Saturday 7 November 2026
Export VTR’s income statement to Excel — free account
Ventas, Inc.
VTR Real Estate Reit Healthcare Facilities
Ventas, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, up 18.5% from fiscal 2024.
- Revenue
- +23.0%
- EPS
- −6.50%
- Free cash flow
- +20.5%
- Total debt
- −1.07%
Quarter to September 2026, against a year earlier
88.88
0.16
−0.18%
Follow VTR
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
157.18 | 161.45 | 146.04 | 140.69 |
+8 more quarters Free account |
P/S ratio |
6.44 | 6.75 | 6.35 | 6.04 | |
P/FCF ratio |
30.02 | 31.11 | 29.01 | 27.45 | |
P/Operating CF |
89.25 | 78.07 | 98.69 | 74.66 | |
P/B ratio |
2.76 | 2.96 | 2.95 | 2.80 | |
Price to Tangible BV |
2.95 | 3.18 | 3.21 | 3.05 | |
EV/Sales |
8.24 | 8.68 | 8.36 | 8.13 | |
EV/EBITDA |
22.29 | 23.26 | 22.21 | 21.28 | |
EV/Operating CF |
29.23 | 31.04 | 29.80 | 28.81 | |
EV/FCF |
38.41 | 40.03 | 38.19 | 36.98 | |
Quick Ratio |
0.15 | 0.44 | 0.25 | 0.67 | |
Current Ratio |
0.43 | 0.44 | 0.25 | 0.67 | |
Net Debt/EBITDA |
17.95 | 19.38 | 20.68 | 20.75 | |
Debt/Assets |
40.61% | 42.78% | 45.22% | 47.16% | |
Debt/Equity |
0.78 | 0.86 | 0.95 | 1.03 | |
Asset Turnover |
0.24 | 0.23 | 0.23 | 0.22 | |
Operating CF/Net income |
7.49 | 7.89 | 7.06 | 6.72 | |
Capex/Depreciation |
(0.32) | (0.25) | (0.19) | (0.39) | |
Interest Coverage |
1.44 | 1.45 | 1.33 | 1.52 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2.60% | 2.72% | 3.79% | 2.62% | |
Intangible Assets out of Total Assets |
0.03 | 0.04 | 0.04 | 0.04 | |
Share Based Compensation of Revenue |
0.32% | 0.31% | 1.50% | 0.40% | |
Graham Net Nets |
(0.32) | (0.33) | (0.36) | (0.40) | |
Graham Number |
19.38 | 19.28 | 18.68 | 18.50 | |
Earnings Yield |
0.64% | 0.62% | 0.68% | 0.71% | |
Free Cash Flow Yield |
3.33% | 3.21% | 3.45% | 3.64% | |
Revenue per Share |
3.56 | 3.54 | 3.48 | 3.44 | |
Operating CF per Share |
0.95 | 1.14 | 0.83 | 1.04 | |
Capex per Share |
(0.28) | (0.21) | (0.15) | (0.30) | |
Free Cash Flow per Share |
0.67 | 0.93 | 0.68 | 0.73 | |
Cash per Share |
0.45 | 0.46 | 0.42 | 1.73 | |
Shareholders Equity per Share |
30.86 | 30.05 | 27.68 | 27.66 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
30.86 | 30.05 | 27.68 | 27.66 | |
Free Cash Flow |
345.06 | 454.72 | 321.64 | 333.95 | |
Working Capital |
(895.53) | (831.72) | (1,016.90) | (453.87) | |
Capital Expenditures |
(144.55) | (101.83) | (72.96) | (137.71) | |
Net Current Asset Value |
(14,093.80) | (14,293.12) | (14,165.88) | (14,076.09) | |
EV/EBIT |
61.62 | 62.33 | 59.04 | 55.32 | |
Capex to Sales |
0.08 | 0.06 | 0.04 | 0.09 | |
Price to Operating Income |
48.16 | 48.43 | 44.85 | 41.07 | |
| Other line items | |||||
Average Receivables |
— | 310.03 | 141.12 | 144.36 | |
Average Payables |
1,348.09 | 1,240.83 | 1,184.10 | 1,196.56 | |
Average Assets |
28,775.54 | 28,065.42 | 26,859.42 | 26,889.43 | |
Average Common Equity |
14,141.71 | 13,147.51 | 12,354.06 | 11,707.71 |
Columns are period end dates · fundamentals updated 6 Nov 2026